文献速递泌尿系结石

肌内注射酮咯酸预防拔除输尿管支架后肾绞痛的有效性:随机对照试验

Efficacy of Intramuscular Ketorolac for Preventing Renal Colic Post Stent Removal: Randomized Controlled Trial.
PubMed 文献 · J Urol · 2022-06-02

这项前瞻性、随机、双盲、安慰剂对照试验纳入124例患者,评价拔支架前肌内注射酮咯酸30 mg与安慰剂的效果。两组拔支架后1天和7天平均疼痛评分及严重疼痛比例无差异,但酮咯酸组因肾绞痛相关非计划急诊/门诊就诊者占2%,低于对照组的13%(p=0.032)。作者认为符合条件的患者可从拔支架时常规使用酮咯酸注射中获益。

要点

  • 拔支架前肌内注射酮咯酸30 mg未显著降低拔支架后总体主观疼痛。
  • 酮咯酸组肾绞痛相关非计划急诊/门诊就诊为2%,对照组为13%(p=0.032)。
  • 作者认为符合条件的患者可从拔支架时常规使用酮咯酸注射中获益。

核心结论

  • 拔支架前给予酮咯酸虽未显著降低拔支架后总体主观疼痛,但降低了需急诊或门诊就诊的严重肾绞痛发生风险。
  • 作者认为符合条件的患者可从拔支架时常规使用酮咯酸注射中获益。

研究设计与样本

  • 前瞻性、随机、双盲、安慰剂对照试验,评估拔支架时给予酮咯酸的效果。
  • 患者随机接受拔支架前即刻肌内注射酮咯酸30 mg或安慰剂。
  • 共纳入124例患者,对照组和治疗组各62例。
  • 拔支架后1天和7天联系患者,评估疼痛、阿片类药物需求、急诊或门诊就诊及手术/内科干预需求。

主要发现

  • 两组人口学/手术特征具有可比性。
  • 拔支架后1天和7天,两组平均疼痛评分及经历严重疼痛的患者比例均未检出差异。
  • 酮咯酸组肾绞痛相关非计划急诊/门诊就诊为2%,对照组为13%(p=0.032),酮咯酸组显著更少。

临床怎么用

  • 作者认为符合条件的患者可从拔支架时常规使用酮咯酸注射中获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The treatment of stones ureteroscopically is associated with postoperative pain, thought to be due largely to the use of ureteral stents. In some, stent removal precipitates renal colic that can last from minutes to hours. We sought to determine if intramuscular ketorolac could reduce post-stent removal renal colic. MATERIALS AND METHODS: We performed a prospective, randomized, double-blind, placebo-controlled trial assessing the effects of ketorolac administered at time of stent removal. Patients were randomized to receive an intramuscular ketorolac 30 mg or placebo immediately prior to stent removal. Patients were contacted 1 and 7 days after stent removal to assess pain, need for opioids, emergency department or clinic visits and the need for surgical/medical interventions. RESULTS: A total of 124 patients (62 patients each in the control and treatment groups) were included in the study. The groups were comparable in demographic/operative characteristics. No difference in mean pain scores or proportion of patients who experienced severe pain at 1 and 7 days post stent removal was detected between groups. However, use of ketorolac resulted in significantly fewer renal colic-related unplanned emergency department/clinic visits in the treatment group (2%) compared with the control group (13%, p=0.032). CONCLUSIONS: Although administration of ketorolac prior to stent removal does not significantly reduce overall subjective pain experienced post stent removal compared to placebo, it does reduce the likelihood of severe renal colic requiring emergency department or office visits. Eligible patients may benefit from routine use of ketorolac injection at the time of stent removal.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Johnson BA, Sorokin I, Antonelli J, et al. Efficacy of Intramuscular Ketorolac for Preventing Renal Colic Post Stent Removal: Randomized Controlled Trial. J Urol. 2022. PMID: 35653577. doi:10.1097/JU.0000000000002750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。